Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer.

View/Open

Accepted version (64.10Kb)

Date

2017-08

ICR Author

De Bono, Johann

Attard, Gerhardt

Parker, Chris

Marsden,

James, Nicholas

Author

Pezaro, CJ

Omlin, A

Mastris, K

ANZUP Consumer Advisory Panel

Attard, G

Beer, TM

Chi, KN

Chowdhury, S

Davis, ID

Drake, CG

de Bono, JS

Efstathiou, E

Gravis, G

Higano, CS

Hussain, M

James, N

Logothetis, CJ

Morgans, A

Parker, C

Ryan, CJ

Saad, F

Sartor, O

Small, EJ

Sternberg, CN

Sweeney, CJ

Tannock, I

Tombal, B

Gillessen, S

Show allShow less

Type

Journal Article

Metadata

Show full item record

URI

https://repository.icr.ac.uk/handle/internal/1236

DOI

https://doi.org/10.1093/annonc/mdx312

Collections

• Clinical Studies
• Molecular Pathology
• Radiotherapy and Imaging

Subject

ANZUP Consumer Advisory Panel

Humans

Male

Terminology as Topic

Prostatic Neoplasms, Castration-Resistant

Research team

Prostate Cancer Targeted Therapy Group

Treatment Resistance

Prostate and Bladder Cancer Research

Language

eng

Date accepted

2017-06-19

License start date

2017-08

Citation

Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (8), pp. 1692 - 1694